/Companies

Healthtech Startups

18,778 companies tagged Healthtech, with their investors and founders.

Trio Pharmaceuticals

Trio Pharmaceuticals develops dual-targeting antibody drugs to treat cancer, using its TIE-ADC and TRAILBody platforms to kill cancer cells and overcome tumor immunosuppression while reducing treatment-related toxicity. Its pipeline targets blood cancers (AML/MDS), ovarian and endometrial cancers, and triple-negative breast and non-small cell lung cancers.

0 investors

Trivascular Health

0 investors

Trove Health Tech

0 investors

TrovRx

0 investors

Tru Dental

0 investors

TruBlu Dental

0 investors

Truclinic

0 investors

TruDataRx

TruDataRx applies comparative effectiveness research to help employer plan sponsors optimize pharmacy formulary coverage decisions based on clinical efficacy data rather than rebate incentives. The company combines peer-reviewed scientific research with proprietary analytics to reduce prescription drug spending while improving member outcomes.

0 investors

True Health

0 investors

True Health Group

0 investors

True Level Investments

0 investors

True North Health Navigation

0 investors

Trugenomix Health

0 investors

TruHealth LLC/FA

0 investors

Trumpet Search

0 investors

Truth Holdings

0 investors

Truvic Medical

0 investors

Tsnc

0 investors

Tucson Concussion Center

0 investors

Tula Health

0 investors

Turbett Surgical

Turbett Surgical develops the Instrument Pod, a system for storing and turning over surgical instrument sets in operating rooms to reduce room turnover time and inventory needs. It serves hospitals and surgical facilities in the medical device industry.

0 investors

Turn Medical

Turn Medical develops and manufactures the Pronova-O2 Automated Prone Therapy System, a medical device for repositioning critically ill patients to improve patient outcomes and caregiver safety. The company serves clinicians, hospitals, and clinical institutions.

0 investors

Turn Therapeutics

Turn Therapeutics develops topical therapies for skin diseases using its proprietary PermaFusion drug delivery platform. The company's lead program, GX-03, is designed to treat moderate to severe eczema by reducing IL-36 signaling and downstream inflammatory cytokines.

0 investors

Turnpoint Medical Devices

0 investors

Other sectors & tags